You are here

Article Text

Article menu
Download PDFPDF
LETTER
Congenital chylothorax: what is the best strategy?
  1. D Mitanchez1,
  2. E Walter-Nicolet1,
  3. R Salomon1,
  4. F Bavoux2,
  5. P Hubert3
  1. 1Departement de Pédiatrie, Hôpital Necker-Enfants Malades, Paris, France
  2. 2Unité de Pharmacovigilance, Hôpital Saint Vincent de Paul, Paris, France
  3. 3Departement de Pédiatrie, Hôpital Necker-Enfants Malades, Paris, France
  1. Correspondence to:
    Dr Delphine Mitanchez
    Service de Réanimation Pédiatrique et Néonatale, Hôpital Necker-Enfants Malades, 149 rue de Sèvres, 75015 Paris, France; delphine.mitanchez{at}nck.ap-hop-paris.fr

http://dx.doi.org/10.1136/adc.2004.069690

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Chemical pleurodesis with povidone-iodine has recently been proposed in persistent congenital chylothorax as an alternative method to surgery.1 We report the case of a neonate treated by povidone-iodine pleurodesis who developed shock and chronic renal failure.

    A bilateral chylothorax with fetal hydrops was diagnosed in a foetus at 34 weeks. Bilateral pleuroamniotic tubes were inserted and maintained until birth at 35 weeks gestation. The 3040 g female infant presented with respiratory distress. A bilateral pleural effusion rapidly re-occurred necessitating total parenteral nutrition and …

    View Full Text

    Footnotes

    • Competing interests: none declared

    • Consent was received for the publication of these patient details